[Inhibition of metabolism of triglyceride-rich lipoproteins by postheparin lipolytic activity in hyperlipoproteinemia type III].
D002784:Cholesterol / Q000032:analysis; D002914:Chylomicrons / Q000032:analysis; D005260:Female; D006493:Heparin / Q000494:pharmacology*; D006801:Humans; D006949:Hyperlipidemias / Q000378:metabolism*; D008074:Lipoproteins / Q000037:antagonists & inhibitors / Q000378:metabolism*; D008077:Lipoproteins, LDL / Q000097:blood; D008079:Lipoproteins, VLDL / Q000097:blood; D008875:Middle Aged; D014280:Triglycerides / Q000032:analysis* / Q000097:blood
D002914:Chylomicrons; D008074:Lipoproteins; D008077:Lipoproteins, LDL; D008079:Lipoproteins, VLDL; D014280:Triglycerides; D006493:Heparin; D002784:Cholesterol
Inhibierung der Metabolisierung triglyzeridreicher Lipoproteine durch die postheparinlipolytischen Aktivitäten bei Hyperlipoproteinämie Typ III.